Zimmer falls after cutting 2025 organic sales growth forecast

Zimmer Biomet Holdings

05/11/2025 12:53

** Shares of medical device maker Zimmer Biomet Holdings ZBH.N fall 8.4% to $94.50 premarket

** ZBH lowers upper end of organic sales growth forecast to 4.0% from 4.5%, maintaining lower end at 3.5%

** Co reports Q3 adj.profit of $1.90/shr vs analysts' average estimate of $1.87/shr - LSEG data

** Co reports quarterly revenue of $2 billion vs analysts' average expectation of $2.01 billion

** Up to last close, stock up ~2% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))